A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease.Casgevy, also ...

An eclectic week of eating great sandwiches, pork belly platters, sushi and pancakes alongside “the world’s best hash browns.

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...

The FireAid benefit was fueled by some of music's best performers to raise money for Los Angeles-area wildfire relief efforts.

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...